Valion Bio raises $50,000 via Series B preferred sale to 3i
Valion Bio entered a letter agreement for 3i to purchase 50 Series B non-voting convertible preferred shares and related warrants.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.